scholarly journals Transcatheter aortic valve implantation: Results of a new therapeutic option for high surgical risk aortic stenosis

2012 ◽  
Vol 31 (2) ◽  
pp. 143-149
Author(s):  
Pablo Salinas ◽  
Raul Moreno ◽  
Luis Calvo ◽  
David Dobarro ◽  
Santiago Jiménez-Valero ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Transcatheter Aortic Valve Implantation ◽  
Therapeutic Option ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

scholarly journals Adoption of Transcatheter Aortic Valve Implantation in Western Europe

2011 ◽  
Vol 9 (1) ◽  
pp. 37 ◽  
Author(s):  
Darren Mylotte ◽  
Ruben LJ Osnabrugge ◽  
Giuseppe Martucci ◽  
Ruediger Lange ◽  
Arie Pieter Kappetein ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Western Europe ◽  
Therapeutic Option ◽  
Surgical Aortic Valve Replacement ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Transcatheter aortic valve implantation (TAVI) is a novel therapeutic option for patients with severe symptomatic aortic stenosis (AS) at excessive or high surgical risk for conventional surgical aortic valve replacement. First commercialised in Europe in 2007, TAVI growth has been exponential among some Western European nations, though recent evidence suggests heterogeneous adoption of this new and expensive therapy. Herein, we review the evidence describing the utilisation of TAVI in Western Europe.

Sign in / Sign up

Export Citation Format

Share Document